Trial intelligence / Profile preview

4CMenB infant systems vaccinology study

2014-000126-38Phase 4Completed

Sponsor
University of Oxford
Start
Mar 2014
Countries
1
01

Overview

Phase 4, randomised, open-label trial of meningococcal group B vaccine in meningococcal disease (2 arms), sponsored by University of Oxford. Started Mar 2014; status: completed.

02

Drugs

meningococcal group B vaccine
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on 2014-000126-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000126-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call